Журнал "Почки" том 9, №3

Ñó÷àñíà ôàðìàêîòåðàï³ÿ / Modern Pharmacotherapy
ние кристаллов мочевой кислоты в осадке мочи и соответствующих
отложений на УЗИ опорно-двигательного
аппарата; применение УСТ и подщелачивания мочи
оправданно в случаях наличия признаков прогрессирования
ХБП, и в качестве обратной связи для оценки эффективности
вмешательства рекомендуется оценивать
изменение скорости прогрессирования ХБП.
Âûâîäû
Согласно рекомендациям, актуальным на текущий
момент, лечение бессимптомной гиперурикемии не
рекомендуется. Тем не менее с помощью анализа осадка
мочи и УЗИ опорно-двигательного аппарата можно
выделить субпопуляцию пациентов, у которых препараты,
снижающие уровень мочевой кислоты, были бы
эффективными. Оба вышеуказанных метода исследования
также могут использоваться в периоде наблюдения
для оценки результатов лечения.
Ñïèñîê ëèòåðàòóðû
1. Thomson T. Chemistry of Animal Bodies. Edinburgh, 1858. P. 31.
2. Viggiano A.A., Viggiano D., Viggiano A.A., De Luca B. Quantitative
histochemical assay for superoxide dismutase in rat brain.
J. Histochem. Cytochem. 2003. 51. 1-7.
3. Wu X., Muzny D., Lee C., Caskey C. Two independent mutational
events in the loss of urate oxidase during hominoid evolution.
J. Mol. Evol. 1992. 34. 78-84.
4. Watanabe S., Kang D.-H., Feng L., Nakagawa T., Kanellis J.,
Lan H., Mazzali M., Johnson R.J. Uric acid, hominoid evolution, and
the pathogenesis of salt-sensitivity. Hypertension. 2002. 40. 355-360.
5. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid
provides an antioxidant defense in humans against oxidant- and
radical-caused aging and cancer: A hypothesis. Proc. Natl. Acad. Sci.
USA. 1981. 78. 6858-6862.
6. Wu X., Wakamiya M., Vaishnav S., Geske R., Montgomery C.,
Jones P., Bradley A., Caskey C.T. Hyperuricemia and urate nephropathy in
urate oxidase-deficient mice. Proc. Natl. Acad. Sci. USA. 1994. 91. 742-746.
7. Sautin Y.Y., Johnson R.J. Uric acid: the oxidant-antioxidant
paradox. Nucleotides Nucleic Acids. 2008. 27.
8. Chen X., Burdett T.C., Desjardins C.A., Logan R., Cipriani S.,
Xu Y., Schwarzschild M.A. Disrupted and transgenic urate oxidase
alter urate and dopaminergic neurodegeneration. Proc. Natl. Acad.
Sci. 2013. 110. 2-7.
9. Shao T., Shao L., Li H., Xie Z., He Z., Wen C. Combined
Signature of the Fecal Microbiome and Metabolome in Patients with
Gout. Front Microbiol. 2017. 8. 268.
10. Guo Z., Zhang J., Wang Z., Ang K.Y., Huang S., Hou Q.,
Su X., Qiao J., Zheng Y., Wang L., Koh E., Danliang H., Xu J.,
Lee Y.K., Zhang H. Intestinal Microbiota Distinguish Gout Patients
from Healthy Humans. Sci. Rep. 2016. 6. 20602.
11. Taniguchi K., Tamura Y., Kumagai T., Shibata S., Uchida
S. Stimulation of V1a receptor increases renal uric acid clearance
via urate transporters: insight into pathogenesis of hypouricemia in
SIADH. Clin. Exp. Nephrol. 2016. 20. 845-852.
12. Zacchia M., Di Iorio V., Trepiccione F., Caterino M., Capasso
G. The Kidney in Bardet-Biedl Syndrome: Possible Pathogenesis of
Urine Concentrating Defect. Kidney Dis. 2017. 3. 57-65.
13. Nigro M., Viggiano D., Ragone V., Trabace T., Di Palma A.,
Rossini M., Capasso G., Gesualdo L., Gigliotti G. A crosssectional
study on the relationship between hematological data and quantitative
morphological indices from kidney biopsies in different glomerular
diseases. BMC Nephrol. 2018. 19. 62.
14. Garrod A. The nature and treatment of gout and rheumatic
gout. Ed. 2. London, 1863.
15. Talbott J.H., Terplan K.L. The kidney in gout. Medicine (Baltimore).
1960. 39. 405-467.
16. Gertler M., Garn S., Levine S. Serum uric acid in relation to
age and physique in health and in coronary heart disease. Ann. Intern.
Med. 1951. 34. 1421-1423.
17. Kohn P., Prozan G. Hyperuricemia; relationship to hypercholesteremia
and acute myocardial infarction. JAMA. 1959. 170. 1909-
1912.
18. Perna A., Di Nunzio A., Amoresano A., Pane F., Fontanarosa
C., Pucci P., Vigorito C., Cirillo G., Zacchia M., Trepiccione
F., Ingrosso D. Divergent behavior of hydrogen sulfide pools and
of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis
patients. Biochimie. 2016. 126. 97-107.
19. Modern F.W., Meister L. The kidney of gout, a clinical entity.
Med. Clin. North. Am. 1952. 21. 941-951.
20. Rieselbach R.E., Sorensen L.B., Shelp W.D., Steele T.H. Diminished
renal urate secretion per nephron as a basis for primary gout.
Ann. Intern. Med. 1970. 73. 359-366.
21. Zacchia M., Capasso G. Parvalbumin: A Key Protein in the
Early Distal Tubule NaCl Reabsorption. Nephrol. Dial. Transpl.
2008. 23. 1109-UU.
22. Waisman J., Bluestone R., Klinenberg J. A preliminary report
of nephropathy in hyperuricemic rats. Lab. Invest. 1974. 30. 716-722.
23. Kuhn T.S. The Structure of Scientific Revolutions. Chicago:
University of Chicago Press, 1996.
24. Linnane J.W., Burry A.F., Emmerson B.T. Urate deposits in
the renal medulla. Prevalence and associations. Nephron. 1981. 29.
216-222.
25. Murray T., Goldberg M. Chronic interstitial nephritis: etiologic
factors. Ann. Intern. Med. 1975. 82. 453-459.
26. Duncan H., Dixon A.S. Gout, familial hypericaemia, and renal
disease. Q. J. Med. 1960. 29. 127-135.
27. Berger L., Yu T.F. Renal function in gout. IV. An analysis of
524 gouty subjects including long-term follow-up studies. Am. J. Med.
1975. 59. 605-613.
28. Batuman V., Maesaka J.K., Haddad B., Tepper E., Landy E.,
Wedeen R.P. The role of lead in gout nephropathy. N. Engl. J. Med.
1981. 304. 520-523.
29. Craswell P.W., Price J., Boyle P.D., Heazlewood V.J., Baddeley
H., Lloyd H.M., Thomas B.J., Thomas B.W. Chronic renal
failure with gout: a marker of chronic lead poisoning. Kidney Int.
1984. 26. 319-323.
30. Beck L.H., Harrinoton J.T., Kairer J.P. Requiem for gouty
nephropathy. Kidney Int. 1986. 30. 280-287.
31. Becker M.A., Jolly M. Hyperuricemia and Associated Diseases.
Rheum. Dis. Clin. North Am. 2006. 32. 275-293.
32. Segura J., Campo C., Ruilope L.M. How relevant and frequent
is the presence of mild renal insufficiency in essential hypertension?
J. Clin. Hypertens. 2002. 4. 332-336.
33. Petrazzuolo O., Trepiccione F., Zacchia M., Capasso G. Hypertension
and renal calcium transport. J. Nephrol. 2010. 23. S112-
S117.
34. Dahan K., Devuyst O., Smaers M., Vertommen D., Loute G.,
Poux J.-M., Viron B., Jacquot C., Gagnadoux M.F., Chauveau D.,
64 Íèðêè, ISSN 2307-1257 (print), ISSN 2307-1265 (online) Òîì 9, ¹ 3, 2020